Glucagon-Like Peptide 1 Receptor Agonist Use and Vertebral Fracture Risk in Type 2 Diabetes.
JAMA Surg · 2026
Last updated 2026-05-28| Journal | JAMA Surg, 2026 |
|---|---|
| Citations | 1 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes |
Full record and abstract on PubMed 41369924 ↗